DYNE THERAPEUTICS INC's ticker is DYN and the CUSIP is 26818M108. A total of 95 filers reported holding DYNE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $101,710 | -20.4% | 11,364 | +0.1% | 0.00% | – |
| Q2 2023 | $127,799 | -2.0% | 11,350 | +0.1% | 0.00% | – |
| Q1 2023 | $130,458 | -98.7% | 11,339 | -99.3% | 0.00% | -100.0% |
| Q3 2022 | $9,735,726 | +33.5% | 1,531,906 | +44.5% | 0.01% | +40.0% |
| Q2 2022 | $7,293,000 | -35.9% | 1,060,301 | -10.3% | 0.01% | 0.0% |
| Q1 2022 | $11,386,000 | +64.5% | 1,182,706 | +103.1% | 0.01% | +66.7% |
| Q4 2021 | $6,923,000 | -23.7% | 582,298 | +4.3% | 0.00% | -25.0% |
| Q3 2021 | $9,070,000 | -24.0% | 558,483 | -1.5% | 0.00% | -20.0% |
| Q2 2021 | $11,933,000 | -11.1% | 567,166 | -34.4% | 0.01% | -16.7% |
| Q1 2021 | $13,419,000 | +1.5% | 864,074 | +37.2% | 0.01% | 0.0% |
| Q4 2020 | $13,227,000 | -33.6% | 629,852 | -36.1% | 0.01% | -40.0% |
| Q3 2020 | $19,912,000 | – | 985,963 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 4,951,303 | $104,175,000 | 19.37% |
| Vida Ventures Advisors, LLC | 2,960,046 | $62,280,000 | 15.62% |
| Logos Global Management LP | 2,054,392 | $43,224,000 | 3.63% |
| GREAT POINT PARTNERS LLC | 672,559 | $14,151,000 | 2.97% |
| Octagon Capital Advisors LP | 583,649 | $12,280,000 | 2.54% |
| COMMODORE CAPITAL LP | 305,125 | $6,420,000 | 2.24% |
| RA Capital Management | 2,805,045 | $59,018,000 | 0.95% |
| Altium Capital Management LP | 166,636 | $3,506,000 | 0.81% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 135,000 | $2,840,000 | 0.75% |
| Soleus Capital Management, L.P. | 178,360 | $3,753,000 | 0.58% |